The Chin lab is interested in the molecular mechanisms that mediate the development of cardiomyopathies, with a particular focus on the genetic events that occur within the myocardium that result in myocardial dysfunction. Major areas of interest include the pathogenesis of hypertrophic cardiomyopathy (HCM), an inherited disorder that affects approximately 1 in 500, development of an enzyme replacement therapy for Barth Syndrome (BTHS), an inherited cardiomyopathy resulting from mitochondrial dysfunction.
AB, Princeton University
MS, Biochemistry, University of Rochester
PhD, Biochemistry, University of Rochester
MD, University of Rochester
Postdoctoral Training, National Institute of Aging, NIH; Harvard School of Public Health